Travere Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Travere Therapeutics shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $14M | 12M | 1.18 |